510(k) Report

510(k) · Cleared

Recalled · Class I · 2023

Triage Cardio Profiler/Triage Cardiac Panel

K030286510(k) SpecialCleared Feb 21, 200324-day reviewClass II21 CFR 862.1117Recalls 3 (2 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biosite Incorporated · NBC Test, Natriuretic Peptide

Cleared on Feb 21, 2003 as substantially equivalent to K973126 (Biosite Incorporated, 1997) and 1 other predicate after a 24-day review. Its family tree reaches back 1 generation to 1997. 1 of the 6 devices in its family, counting itself, has a Class I recall. 3 later devices descend from it. It has been recalled 3 times, including 2 Class I recalls.

Decided
Feb 21, 2003
Review
24 days
Class
Class II
Product code
NBC
Recalls
3 (2 Class I)
Predicates
2

Its longest line of descent runs back 1 generation to K973126 (1997). 2 ancestors in all. 3 later devices descend from it, 1 citing it directly. 1 of the 6 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2002: 1 other ancestor2010: 1 descendant cleared2014: 1 descendant cleared2011: 1 descendant clearedK973126 · Triage Cardiac Panel, Triage Troponin-I, Triage CK-MB, Triage Myoglobin, Triage Troponin-I and CK-MB, Triage Troponin-I · Biosite Incorporated · 19971995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 2 descendants K973126 · Triage Cardiac Panel, Triage Troponin-I, Triage CK-MB, Triage Myoglobin, Triage Troponin-I and CK-MB, Triage Troponin-I · Biosite Incorporated · 19970
  1. Root · 1 generation backK973126 Triage Cardiac Panel, Triage Troponin-I, Triage CK-MB, Triage…Biosite Incorporated · 1997
  2. This deviceK030286 Triage Cardio Profiler/Triage Cardiac PanelBiosite Incorporated · 2003
  3. Descendant · cites it directly · 2 of its ownK093758 BGM Galectin -3Bg Medicine, Inc. · 2010
  4. Descendant · 2 generations on · 0 of its ownK140436 ARCHITECT GALECTIN-3 Reagent Kit, ARCHITECT GALECTIN-3 CALIBRATORS…Fujirebio Diagnostics,Inc. · 2014
  5. Descendant · 2 generations on · 0 of its ownK111452 Presage ST2 AssayCritical Care Diagnostics, Inc. (Dba Critical Diag · 2011 · Recalled

Most influential descendants

Showing 3 of 3 · See all
  • K093758BGM Galectin -3Bg Medicine, Inc. · 2010 · cites it directly2descendants
  • K140436ARCHITECT GALECTIN-3 Reagent Kit, ARCHITECT GALECTIN-3 CALIBRATORS, ARCHITECT GALECTIN-3…Fujirebio Diagnostics,Inc. · 2014 · 2 generations on0descendants
  • K111452Presage ST2 AssayCritical Care Diagnostics, Inc. (Dba Critical Diag · 2011 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K973126Triage Cardiac Panel, Triage Troponin-I, Triage CK-MB, Triage Myoglobin…Biosite Incorporated1997—
0 (this device)K030286Triage Cardio Profiler/Triage Cardiac PanelBiosite Incorporated2003—
+1K093758BGM Galectin -3Bg Medicine, Inc.2010—
+2K140436ARCHITECT GALECTIN-3 Reagent Kit, ARCHITECT GALECTIN-3 CALIBRATORS, ARCHITECT…Fujirebio Diagnostics,Inc.2014—
+2K111452Presage ST2 AssayCritical Care Diagnostics, Inc. (Dba Critical Diag20111

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201110
201410
FIG. 1 — Lineage of K030286, 1997–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBC device

  1. #1 K262109 Access NT-proBNPscore 13.8 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K973126Triage Cardiac Panel, Triage Troponin-I, Triage CK-MB, Triage Myoglobin, Triage…
Summary page 1
…Test, Natriuretic Peptide (862.1 117) (Triage@Cardio ProfiIER) Product Code NBC C. Predicate Devices Triage@Cardiac Panel (K973126) ” y Triage@BNP Test…
Biosite Incorporated1997—
*K021317Triage B-Type Natriuretic Peptide (BNP) TestBiosite Incorporated2002—

Also cleared against K973126: 4 other devices →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K093758BGM Galectin -3Bg Medicine, Inc.20102

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 25, 2023Class IZ-1974-2023Nonconforming Material/ComponentRaw material issue may cause cardiac panel products to have an average of 30% troponin signal reduction across measurement range 0.05 ng/mL to 30 ng/mL, QC testing won't detect anomaly, so an alternate method is recommended, if…
May 22, 2012Class IZ-1929-2012Process designCertain lots of the affected products may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results. These false positive and false…
Apr 27, 2009Not classifiedZ-1391-2009Process controlThe recall was initiated because the use of the affected lot may lead to reporting falsely low values for troponin I and myoglobin, possibly resulting in missed or incorrect diagnosis.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • Of its descendants, K093758 (Bg Medicine, Inc., 2010) has gone furthest, with 2 descendants of its own.
  • 4 other devices also cite its predicate K973126.

How does its category compare?

All NBC devices

NBC Test, Natriuretic Peptide: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NBC

1in 2025

2007: 22008: 72010: 12020: 12021: 22022: 12023: 22024: 12025: 12026 (partial year): 4
2007high 7 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBC

126in 2008

2008: 126 days median2026 (partial year): 94 days median
2007high 126 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBC

1in 2020

2010: 12012: 22014: 12015: 12018: 12020: 1
2007high 2 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NBC

17in 2025

2007: 172008: 152009: 352010: 612011: 532012: 232013: 132014: 702015: 432016: 312017: 92018: 72019: 92020: 62022: 42023: 262024: 142025: 17
2007high 70 (2014) · low 0 (2021)2025

MAUDE reports naming product code NBC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—017
20087126015
20090—035
20101—161
20110—053
20120—223
20130—013
20140—170
20150—143
20160—031
20170—09
20180—17
20190—09
20201—16
20212—00
20221—04
20232—026
20241—014
20251—017
20264940—

What is it indicated for?

The Triage@ Cardio ProfilER is a fluorescence immunoassay to be used with the Triage@Meter for the quantitative determination of Creatine Kinase MB, myoglobin, troponin I, and B-type natriuretic peptide in EDTA whole blood and plasma specimens. The test is used as an aid in the diagnosis of myocardial infarction (injury), the diagnosis and assessment of severity of congestive heart failure (also referred to as heart failure), and the risk stratification…

Read the full statement (123 words)

The Triage@ Cardio ProfilER is a fluorescence immunoassay to be used with the Triage@Meter for the quantitative determination of Creatine Kinase MB, myoglobin, troponin I, and B-type natriuretic peptide in EDTA whole blood and plasma specimens. The test is used as an aid in the diagnosis of myocardial infarction (injury), the diagnosis and assessment of severity of congestive heart failure (also referred to as heart failure), and the risk stratification of patients with acute coronary syndromes.

The Triage03 Cardiac Panel is a fluorescence immunoassay to be used with the Triage@Meter for the quantitative determination of Creatine Kinase MB, myoglobin and troponin I in EDTA whole blood and plasma specimens. The test is used as an aid in the diagnosis of myocardial infarction (injury).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K030286: Triage Cardio Profiler/Triage Cardiac Panel.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K030286

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026